ctDNA dynamics, prognostic markers and resistance mechanisms in tepotinib-treated MET exon 14 (METex14) skipping NSCLC in the VISION trial Meeting Abstract


Authors: Le, X.; Garassino, M. C.; Ahn, M. J.; Felip, E.; Cortot, A. B.; Sakai, H.; Mazières, J.; Thomas, M.; Viteri, S.; Conte, P.; Yang, J. C. H.; Lams, W. T.; Griesinger, F.; O'Hara, R. M. Jr; Stroh, C.; Juraeva, D.; Wang, D.; Johne, A.; Paik, P. K.
Abstract Title: ctDNA dynamics, prognostic markers and resistance mechanisms in tepotinib-treated MET exon 14 (METex14) skipping NSCLC in the VISION trial
Meeting Title: 2023 North America Conference on Lung Cancer
Journal Title: Journal of Thoracic Oncology
Volume: 19
Issue: 7 Suppl.
Meeting Dates: 2023 Dec 1-3
Meeting Location: Chicago, IL
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2024-07-01
Start Page: e4
Language: English
ACCESSION: WOS:001277064200006
PROVIDER: wos
DOI: 10.1016/j.jtho.2024.05.149
Notes: Meeting Abstract: PPD01.01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik